Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status.
FMS-like tyrosine kinase 3 receptor (FLT3) internal tandem duplication (ITD) mutations result in constitutive activation of this receptor and have been shown to increase the risk of relapse in patients with acute myeloid leukemia (AML); however, substantial heterogeneity in clinical outcomes still e...
Main Authors: | Alessandra Cesano, Santosh Putta, David B Rosen, Aileen C Cohen, Urte Gayko, Kavita Mathi, John Woronicz, Rachael E Hawtin, Larry Cripe, Zhuoxin Sun, Martin S Tallman, Elisabeth Paietta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3576376?pdf=render |
Similar Items
-
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).
by: David B Rosen, et al.
Published: (2010-01-01) -
Racial differences in B cell receptor signaling pathway activation
by: Longo Diane M, et al.
Published: (2012-06-01) -
Role of misfolded N-CoR mediated transcriptional deregulation of Flt3 in acute monocytic leukemia (AML)-M5 subtype.
by: Dawn Sijin Nin, et al.
Published: (2012-01-01) -
Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells.
by: Bui Thi Kim Ly, et al.
Published: (2013-01-01) -
Overcoming Resistance to FLT3 Inhibitors in the Treatment of <i>FLT3</i>-Mutated AML
by: Stephen S.Y. Lam, et al.
Published: (2020-02-01)